Tenapanor: Phase IIb data

A double-blind, international Phase IIb trial in 161 ESRD patients with hyperphosphatemia on hemodialysis showed that oral tenapanor met the

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE